Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

10.81
Delayed Data
As of Mar 27
 +0.06 / +0.56%
Today’s Change
10.35
Today|||52-Week Range
38.50
-25.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Operating ActivitiesNet Income / Starting Line-372.9M-325.9M-1.2B-462.3M
 
 
 
 
 
Depreciation746.8M751.0M698.9M649.1M
 
 
 
 
 
Total Other Cash Flow159.9M174.7M1.3B262.4M
 
 
 
 
 
Funds From Operations507.6M456.1M591.0M530.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-50.2M42.5M58.9M58.1M
 
 
 
 
 
Net Cash Flow - Operating Activities557.8M413.6M532.1M472.4M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-1.4M21.2K431.2K
 
 
 
 
Decrease In Investments0.0015.7M1.1M95.8K
 
 
 
 
Capital Expenditures-62.3M-70.1M-51.8M-50.8M
 
 
 
 
 
Fixed Asset Disposal6.3M108.7M18.7M63.9M
 
 
 
 
 
Net Assets From Acquisitions -48.7M-1.6M736.1K30.7M
 
 
 
 
 
Other Investing - Uses0.000.000.00-29.8M
 
 
Net Cash Flow Investing-112.0M47.9M-69.6M9.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00309.7K-411.4K3.1M
 
 
 
 
Long Term Borrowings1.2B39.4M-18.5M-20.9M
 
 
 
 
 
Long Term Debt Reduction-425.6M-888.7M-635.8M-488.9M
 
 
 
 
 
Net Proceeds Stock Sale800.0K-77.4K32.9M-669.6K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing----------
Other Uses - Financing535.7M57.9M44.9M39.7M
 
 
 
 
 
Net Cash Flow - Financing259.5M-906.9M-666.8M-538.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash7.8M-4.4M3.1M-60.1M
 
 
 
 
 
 
Net Change In Cash705.3M-445.4M-204.2M-56.7M